Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:AACH NASDAQ:BACK OTCMKTS:FCHS OTCMKTS:VYNT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAACHAAC$0.03+46.8%$0.03$0.01▼$0.84$805KN/A96,753 shs891,800 shsBACKIMAC$0.08-17.3%$0.06$0.03▼$2.10$168K2.19624,822 shs3,736 shsFCHSFirst Choice Healthcare Solutions$0.01+58.8%$0.01$0.00▼$0.01$419K0.9961,609 shs346,500 shsVYNTVyant Bio$0.19+7.8%$0.19$0.14▼$1.58$1.23M1.73161,822 shs19,100 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAACHAAC0.00%0.00%0.00%0.00%0.00%BACKIMAC+38.03%+30.49%+5.95%+210.13%-94.49%FCHSFirst Choice Healthcare Solutions-27.93%-20.00%-6.98%+33.33%+74.10%VYNTVyant Bio0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAACHAACN/AN/AN/AN/AN/AN/AN/AN/ABACKIMACN/AN/AN/AN/AN/AN/AN/AN/AFCHSFirst Choice Healthcare Solutions0.7424 of 5 stars0.03.00.00.02.91.70.0VYNTVyant BioN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAACHAAC 0.00N/AN/AN/ABACKIMAC 0.00N/AN/AN/AFCHSFirst Choice Healthcare Solutions 0.00N/AN/AN/AVYNTVyant Bio 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAACHAACN/AN/AN/AN/AN/AN/ABACKIMAC$72.05K2.33N/AN/A($0.66) per share-0.12FCHSFirst Choice Healthcare Solutions$30K13.95N/AN/A($0.99) per share-0.01VYNTVyant Bio$670K1.83N/AN/A$1.69 per share0.11Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAACHAACN/AN/A0.00∞N/AN/AN/AN/AN/ABACKIMAC-$9.42MN/A0.00∞N/AN/AN/A-325.44%11/3/2025 (Estimated)FCHSFirst Choice Healthcare Solutions-$3.85M-$0.09N/A∞N/AN/AN/A-63.12%N/AVYNTVyant Bio-$22.69MN/A0.00∞N/A-3,474.81%-151.82%-97.14%N/ALatest FCHS, VYNT, AACH, and BACK EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025FCHSFirst Choice Healthcare SolutionsN/A-$0.02N/A-$0.02N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAACHAACN/AN/AN/AN/AN/ABACKIMACN/AN/AN/AN/AN/AFCHSFirst Choice Healthcare SolutionsN/AN/AN/AN/AN/AVYNTVyant BioN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAACHAACN/AN/AN/ABACKIMACN/A0.080.08FCHSFirst Choice Healthcare SolutionsN/AN/AN/AVYNTVyant Bio0.042.862.86Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAACHAACN/ABACKIMAC5.84%FCHSFirst Choice Healthcare SolutionsN/AVYNTVyant BioN/AInsider OwnershipCompanyInsider OwnershipAACHAAC31.22%BACKIMAC12.26%FCHSFirst Choice Healthcare Solutions30.81%VYNTVyant Bio9.56%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAACHAAC1,90025.16 millionN/ANot OptionableBACKIMAC1802.07 million1.82 millionNot OptionableFCHSFirst Choice Healthcare Solutions20732.96 million22.80 millionNot OptionableVYNTVyant Bio306.33 million5.72 millionNot OptionableFCHS, VYNT, AACH, and BACK HeadlinesRecent News About These CompaniesBio vs non-bio washing powderAugust 7, 2024 | which.co.ukWWhat is Biotechnology?August 4, 2024 | bio.orgBVyant Bio files Certificate of Dissolution with State of DelawareDecember 26, 2023 | msn.comVyant Bio Inc VYNTDecember 19, 2023 | morningstar.comMVyant Bio, Inc.: Vyant Bio Provides Update on Winddown ActivitiesNovember 11, 2023 | finanznachrichten.deVyant Bio expects to start liquidation payments in Q4 2024November 10, 2023 | msn.comVyant Bio Provides Update on Winddown ActivitiesNovember 10, 2023 | finance.yahoo.comVyant Bio, Inc.: Vyant Bio Announces Stockholder Approval of Plan of DissolutionNovember 1, 2023 | finanznachrichten.deVyant Bio shareholders approve plan to dissolve companyNovember 1, 2023 | msn.comVyant Bio Announces Stockholder Approval of Plan of DissolutionNovember 1, 2023 | finance.yahoo.comNamtu Airport, Namtu, Myanmar [ NMT / VYNT ]October 28, 2023 | prokerala.comPLab Notes: Philadelphia health care investment firm closes two funds valued at over $500MOctober 26, 2023 | finance.yahoo.comVyant Bio, Inc.: Vyant Bio Announces Completion of StemoniX Asset SaleOctober 25, 2023 | finanznachrichten.deVyant Bio Announces Completion of StemoniX Asset SaleOctober 24, 2023 | finance.yahoo.comVyant Bio Announces Stockholder Approval of Proposed Asset Sale; 64,110 Votes Needed to Approve Plan of Dissolution; and Adjournment of Special Meeting of StockholdersOctober 19, 2023 | finance.yahoo.comVyant Bio Announces 77,522 Votes Needed to Approve Sale of Assets 175,721 Votes Needed to Approve Winddown of Business Adjournment of Special Meeting of StockholdersOctober 11, 2023 | finance.yahoo.comVyant Bio, Inc.: Vyant Bio Announces Adjournment of Special Meeting of StockholdersSeptember 29, 2023 | finanznachrichten.deVyant Bio Announces Adjournment of Special Meeting of StockholdersSeptember 20, 2023 | finance.yahoo.comMedicare patients took unnecessary genetic cancer tests in man’s $463M scheme, feds sayAugust 21, 2023 | yahoo.comScientists identify four new breast cancer risk genesAugust 21, 2023 | devdiscourse.comDMedia Sentiment Over Time Top HeadlinesView All HeadlinesWhy the American Eagle Stock Rally Isn't Just Speculation By Gabriel Osorio-Mazilli | July 28, 20253 Companies That Will Profit From Trump's Semiconductor TariffsBy Jordan Chussler | August 14, 20253 Stocks Riding the AI Data Center Buildout WaveBy Chris Markoch | August 6, 20253 Short Squeeze Candidates With Big Catalysts on the HorizonBy Dan Schmidt | July 25, 20253 Dividend Stocks Raising Payouts—and Backing It Up With ResultsBy Gabriel Osorio-Mazilli | August 10, 2025FCHS, VYNT, AACH, and BACK Company DescriptionsAAC OTCMKTS:AACH$0.03 +0.01 (+46.79%) As of 12/14/2020AAC Holdings, Inc. provides inpatient and outpatient substance use treatment services for individuals with drug addiction, alcohol addiction, and co-occurring mental/behavioral health issues in the United States. Its therapy services include motivational interviewing, cognitive behavioral therapy, rational emotive behavior therapy, dialectical behavioral therapy, solution-focused therapy, eye movement desensitization and reprocessing, and systematic family intervention. As of December 31, 2018, the company operated 11 inpatient substance abuse treatment facilities, focused on delivering clinical care and treatment solutions across 1,080 inpatient beds, including 700 licensed detoxification beds, 24 standalone outpatient centers, and 4 sober living facilities across 471 beds for a total of 1,551 combined inpatient and sober living beds. It also offers multi-media marketing services to families and individuals struggling with addiction and seeking treatment options through online directories of treatment providers, treatment provider reviews, forums, and professional communities. In addition, the company performs drug testing and diagnostic laboratory services; and provides physician services to its clients. AAC Holdings, Inc. was founded in 2014 and is headquartered in Brentwood, Tennessee. On June 20, 2020, AAC Holdings, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.IMAC NASDAQ:BACK$0.08 -0.02 (-17.35%) As of 01:58 PM EasternIMAC Holdings, Inc. owns and manages innovative medical advancements and care regeneration centers, and backspace clinics in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides medical treatments, regenerative, spinal decompression, chiropractic manipulation, and physical medicine and therapy. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Franklin, Tennessee.First Choice Healthcare Solutions OTCMKTS:FCHS$0.01 +0.00 (+58.75%) As of 03:03 PM EasternFirst Choice Healthcare Solutions, Inc. provides healthcare services in the United States. It develops primary care and wellness clinics focused on providing life improvement services, such as anti-aging, weight management, hormone replacement, and pharmacy services. The company is headquartered in Melbourne, Florida.Vyant Bio OTCMKTS:VYNT$0.19 +0.01 (+7.78%) As of 12/29/2023Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). The company is based in Cherry Hill, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Medtronic: The Opportunity Gets Healthier for Income Investors Palo Alto Networks Uptrend Confirmed! New Highs Set by Year’s End Micron Stock Still Cheap Despite 25% Rally, Analysts Say Qualcomm Just Passed 1 Major Test, But Can It Pass the Next? Lyft's Billion-Dollar Signal: Why Wall Street Is Betting Big Joby Aviation: Why a Historic Flight Outweighs Analyst Downgrades Buy, Sell, or Hold? Insiders Pile Into These 3 Healthcare Stocks Grab Holdings: Get a Grip Now—Explosive Upside Brewing Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access